Immunotherapy Conferences and Events

Immunotherapy uses the immune system to prevent, control, or treat disease, especially cancer, autoimmune disorders, infectious diseases, and inflammatory conditions. It includes checkpoint inhibitors, therapeutic antibodies, cancer vaccines, adoptive cell therapies, cytokines, immune modulators, and engineered delivery systems. In biotechnology and nanomedicine, immunotherapy intersects with nanovaccines, drug delivery, cell therapy, biomaterials, and precision medicine to improve immune targeting and response.

Immunotherapy matters because it can produce durable disease control by changing how the immune system recognizes and responds to threats. Cancer immunotherapy has transformed treatment for some patients, while immune engineering is expanding into infectious disease, allergy, transplantation, and autoimmune disease. Key challenges include response variability, toxicity, immune suppression, resistance, biomarkers, manufacturing, and patient selection. The field connects closely to cancer nanotechnology, cell therapy, nanovaccines, and therapeutic antibodies.

Conferences on immunotherapy appear in oncology, biotechnology, immunology, nanomedicine, cell therapy, and pharmaceutical research programs. Sessions often cover checkpoint blockade, CAR-T cells, cancer vaccines, immune biomarkers, combination therapies, and clinical translation. Tracking immunotherapy events helps researchers follow one of the most influential areas in modern medicine.

To learn more, read our detailed glossary article on immunotherapy.